Acompanhe as Notícias da Recifes

A new study from researchers at The University of Texas MD Anderson Cancer Center has uncovered how one of the most common genetic alterations in glioma rewires the cancer cell genome to fuel tumor progression, suggesting a potential new therapeutic strategy for patients with ATR

Glaucoma is the leading cause of irreversible visual impairment worldwide. Because the disease often progresses without symptoms for years, many patients are diagnosed only after permanent damage to the optic nerve has already occurred. Earlier detection through targeted screenin

A new study from Virginia Tech suggests patterns of repetitive negative thinking explain how anxiety develops into deeper stress for caregivers of people living with dementia and that mindfulness training may help identify and interrupt that progression.

A new study published in Nature Communications identifies a molecular signaling pathway that contributes to the development of life-threatening aortic aneurysms and dissections in Marfan syndrome, a genetic disorder affecting connective tissue. The findings provide new insight in

An international research team co-led by the Institute of Biomedicine and Biotechnology of Cantabria (IBBTEC-CSIC-University of Cantabria) and CIC bioGUNE, member of BRTA, has identified a novel molecular mechanism that helps limit the progression of several types of cancer.

Results of the Phase III COMPETE clinical trial show that the targeted radiotherapeutic agent [177Lu]Lu-edotreotide significantly prolonged progression-free survival in patients with metastatic gastroenteropancreatic neuroendocrine tumors (GEP-NETs) compared with targeted therapy

Glioblastoma, the most aggressive malignant brain tumor in adults, remains one of the most challenging cancers to treat because of limited treatment options and a poor prognosis. Patient outcomes have remained largely unchanged in the past two decades, underscoring the need for i

The epigenetic modifier MLL4 has an unassuming name—the 4, for instance, indicates it's just one in a family of such modifiers. But MLL4 is quite special: In a specific type of leukemia, it drives disease progression, while in solid tumors, it acts as a suppressor.

A form of glioma, a type of brain cancer, tends to progress toward greater malignancy due to an increasing tendency of glioma cells to transform into immature, stem cell-like states, according to a study led by investigators at Weill Cornell Medicine, the New York Genome Center,

Disease progression in people with Parkinson's disease can be accurately monitored using sensors, removing some of the limitations of wearable technologies, a new study reports. In the study published in the Journal of NeuroEngineering and Rehabilitation, scientists from the UK D

An international research group led by researchers from VUB-UZ Brussels and KU Leuven has demonstrated that a combined approach targeting both the immune system and insulin-producing beta cells can slow the progression of type 1 diabetes more effectively than individual treatment

A new therapy offers people with seemingly incurable brain tumors scope for hope: It could slow the progression of the disease and extend patients' lives.